retatrutide status Availability and Current Status: UK Regulatory Guide – Bolt Pharmacy Retatrutide is changing the game

Although an endogenous OXM receptor has not been identified, OXM exerts weak agonist activity on GLP-1R (106) and the glucagon receptor (GCGR) (107)

However, having a balanced meal or snack beforehand can help ensure that you feel your best after the injection

Bone health is an important consideration during weight loss, making adequate calcium and vitamin D intake along with weight-bearing exercise important components of a comprehensive approach

Mehal, 18 September 2025, npj Metabolic Health and Disease

Months six through twelve: the maintenance transition During the second half of your first year, weight loss continues but at a slower pace

Episodes are brief and resolve without intervention in documented anecdotal accounts